Mohamed F. El‐Mansy

VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents

Eman Y. Ahmed, Nehad A. Abdel Latif, Mohamed F. El‐Mansy et al. · Bioorganic & Medicinal Chemistry · 2020 · 71 citations · Full text

Breast Oncology, Medicine, Breast Cancer +10

Chemical Proteomics-Based Analysis of Off-Target Binding Profiles for Rosiglitazone and Pioglitazone: Clues for Assessing Potential for Cardiotoxicity

Brian Hoffmann, Mohamed F. El‐Mansy, Daniel S. Sem et al. · Journal of Medicinal Chemistry · 2012 · 43 citations · Full text

Assessing Potential, Glitazone Scaffold, Lipid Peroxidation +21

Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives

Eman Y. Ahmed, Weam Salah Goda Elserwy, Mohamed F. El‐Mansy et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 41 citations · Full text

Angiokinase Inhibition, Medicine, Pharmacology +10

Enantioselective Synthesis of (−)‐Halenaquinone

Subir Goswami, Kenichi Harada, Mohamed F. El‐Mansy et al. · Angewandte Chemie International Edition · 2018 · 31 citations

Cross-coupling Reaction, Engineering, Heterocyclic +12

Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents

Farid M. Sroor, Samir Y. Abbas, Wahid M. Basyouni et al. · Bioorganic Chemistry · 2019 · 31 citations

Nanoparticles, Nanoparticle Forms, Medicinal Chemistry +7